209 related articles for article (PubMed ID: 11121428)
21. CD98hc facilitates B cell proliferation and adaptive humoral immunity.
Cantor J; Browne CD; Ruppert R; Féral CC; Fässler R; Rickert RC; Ginsberg MH
Nat Immunol; 2009 Apr; 10(4):412-9. PubMed ID: 19270713
[TBL] [Abstract][Full Text] [Related]
22. CD98hc (SLC3A2) participates in fibronectin matrix assembly by mediating integrin signaling.
Féral CC; Zijlstra A; Tkachenko E; Prager G; Gardel ML; Slepak M; Ginsberg MH
J Cell Biol; 2007 Aug; 178(4):701-11. PubMed ID: 17682053
[TBL] [Abstract][Full Text] [Related]
23. Metabolic activation-related CD147-CD98 complex.
Xu D; Hemler ME
Mol Cell Proteomics; 2005 Aug; 4(8):1061-71. PubMed ID: 15901826
[TBL] [Abstract][Full Text] [Related]
24. The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity.
Digomann D; Kurth I; Tyutyunnykova A; Chen O; Löck S; Gorodetska I; Peitzsch C; Skvortsova II; Negro G; Aschenbrenner B; Eisenhofer G; Richter S; Heiden S; Porrmann J; Klink B; Schwager C; Dowle AA; Hein L; Kunz-Schughart LA; Abdollahi A; Lohaus F; Krause M; Baumann M; Linge A; Dubrovska A
Clin Cancer Res; 2019 May; 25(10):3152-3163. PubMed ID: 30670494
[TBL] [Abstract][Full Text] [Related]
25. CD98hc (SLC3A2) loss protects against ras-driven tumorigenesis by modulating integrin-mediated mechanotransduction.
Estrach S; Lee SA; Boulter E; Pisano S; Errante A; Tissot FS; Cailleteau L; Pons C; Ginsberg MH; Féral CC
Cancer Res; 2014 Dec; 74(23):6878-89. PubMed ID: 25267066
[TBL] [Abstract][Full Text] [Related]
26. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98).
Kanai Y; Segawa H; Miyamoto Ki; Uchino H; Takeda E; Endou H
J Biol Chem; 1998 Sep; 273(37):23629-32. PubMed ID: 9726963
[TBL] [Abstract][Full Text] [Related]
27. The 4F2hc surface antigen is necessary for expression of system L-like neutral amino acid-transport activity in C6-BU-1 rat glioma cells: evidence from expression studies in Xenopus laevis oocytes.
Bröer S; Bröer A; Hamprecht B
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):863-70. PubMed ID: 8554532
[TBL] [Abstract][Full Text] [Related]
28. Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains.
Bröer A; Friedrich B; Wagner CA; Fillon S; Ganapathy V; Lang F; Bröer S
Biochem J; 2001 May; 355(Pt 3):725-31. PubMed ID: 11311135
[TBL] [Abstract][Full Text] [Related]
29. Cross-talk between RANKL and FRP-1/CD98 Systems: RANKL-mediated osteoclastogenesis is suppressed by an inhibitory anti-CD98 heavy chain mAb and CD98-mediated osteoclastogenesis is suppressed by osteoclastogenesis inhibitory factor.
Mori K; Miyamoto N; Higuchi Y; Nanba K; Ito M; Tsurudome M; Nishio M; Kawano M; Uchida A; Ito Y
Cell Immunol; 2001 Feb; 207(2):118-26. PubMed ID: 11243701
[TBL] [Abstract][Full Text] [Related]
30. The role of CD98 heavy chain in cancer development.
Park E; Kim H; Yoon S; Jang B
Histol Histopathol; 2024 Apr; ():18749. PubMed ID: 38695393
[TBL] [Abstract][Full Text] [Related]
31. Enhanced tumorigenicity caused by truncation of the extracellular domain of GP125/CD98 heavy chain.
Hara K; Kudoh H; Enomoto T; Hashimoto Y; Masuko T
Oncogene; 2000 Dec; 19(54):6209-15. PubMed ID: 11175335
[TBL] [Abstract][Full Text] [Related]
32. Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc.
Lee Y; Wiriyasermkul P; Jin C; Quan L; Ohgaki R; Okuda S; Kusakizako T; Nishizawa T; Oda K; Ishitani R; Yokoyama T; Nakane T; Shirouzu M; Endou H; Nagamori S; Kanai Y; Nureki O
Nat Struct Mol Biol; 2019 Jun; 26(6):510-517. PubMed ID: 31160781
[TBL] [Abstract][Full Text] [Related]
33. CD98hc in host-pathogen interactions: roles of the multifunctional host protein during infections.
Vection S; O'Callaghan D; Keriel A
FEMS Microbiol Rev; 2022 Sep; 46(5):. PubMed ID: 35595511
[TBL] [Abstract][Full Text] [Related]
34. TA1/LAT-1/CD98 light chain and system L activity, but not 4F2/CD98 heavy chain, respond to arginine availability in rat hepatic cells. Loss Of response in tumor cells.
Campbell WA; Sah DE; Medina MM; Albina JE; Coleman WB; Thompson NL
J Biol Chem; 2000 Feb; 275(8):5347-54. PubMed ID: 10681508
[TBL] [Abstract][Full Text] [Related]
35. Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cells are mediated by alpha3beta1 integrin and regulated by insulin-like growth factor-1 and CD98.
Chandrasekaran S; Guo NH; Rodrigues RG; Kaiser J; Roberts DD
J Biol Chem; 1999 Apr; 274(16):11408-16. PubMed ID: 10196234
[TBL] [Abstract][Full Text] [Related]
36. Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.
Mastroberardino L; Spindler B; Pfeiffer R; Skelly PJ; Loffing J; Shoemaker CB; Verrey F
Nature; 1998 Sep; 395(6699):288-91. PubMed ID: 9751058
[TBL] [Abstract][Full Text] [Related]
37. Homeostatic and innate immune responses: role of the transmembrane glycoprotein CD98.
Nguyen HT; Merlin D
Cell Mol Life Sci; 2012 Sep; 69(18):3015-26. PubMed ID: 22460579
[TBL] [Abstract][Full Text] [Related]
38. Beta1 integrins show specific association with CD98 protein in low density membranes.
Kolesnikova TV; Mannion BA; Berditchevski F; Hemler ME
BMC Biochem; 2001; 2():10. PubMed ID: 11696247
[TBL] [Abstract][Full Text] [Related]
39. Sequence-specific interaction between the disintegrin domain of mouse ADAM 3 and murine eggs: role of beta1 integrin-associated proteins CD9, CD81, and CD98.
Takahashi Y; Bigler D; Ito Y; White JM
Mol Biol Cell; 2001 Apr; 12(4):809-20. PubMed ID: 11294888
[TBL] [Abstract][Full Text] [Related]
40. CD98hc (SLC3A2) sustains amino acid and nucleotide availability for cell cycle progression.
Cano-Crespo S; Chillarón J; Junza A; Fernández-Miranda G; García J; Polte C; R de la Ballina L; Ignatova Z; Yanes Ó; Zorzano A; Stephan-Otto Attolini C; Palacín M
Sci Rep; 2019 Oct; 9(1):14065. PubMed ID: 31575908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
